What’s new

• Guided 60-70% top-line growth in FY27 and more than 100% in FY28
• Commissioned 3,30,000 MT SSP plant in April 2026; DAP/NPK plant from October 2026
• Capex estimate raised to >₹1,000 cr from ₹700 cr, a 40% overrun

Why it matters

The guidance implies revenue could more than double in two years, a bold bet for a fertilizer company. But the 40% capex overrun weakens the narrative: at a debt/equity of 1.56, the balance sheet is already stretched. Core manufacturing margins held at 13-15%, yet consolidated margins fell to ~10% due to trading, meaning the growth must come from higher-margin NPK, not just volume.

What we’re watching

• Execution ramp-up of the DAP/NPK plant from October 2026
• Whether cost overruns are one-off or signal weak project management
• How the product mix shifts away from trading toward manufacturing

The full read

Madhya Bharat Agro delivered a record FY26 (₹1,867 crore revenue and ₹150 crore PAT) but the real story is the ask. Management expects 60-70% top-line growth in FY27 and more than 100% in FY28, powered by two new Maharashtra plants: a 3,30,000 MT SSP facility already online and a DAP/NPK plant kicking off in October 2026. That would roughly triple revenue in two years. Yet the same call disclosed a 40% cost overrun on the expansion, pushing capex to over ₹1,000 crore from an earlier ₹700 crore. Core manufacturing margins held at 13-15%, but consolidated margins slipped to ~10% because of opportunistic trading. At a market cap of ₹4,968 crore and a trailing P/E of 33.1, the stock already prices in much of the growth. The open question is whether the cost overrun sours the returns on that ₹1,000 crore bet.

Primary source: NSE